Results 121 to 130 of about 1,907 (144)
Some of the next articles are maybe not open access.

Flow Cytometry for Anti-SEMA7A [IPI-mSEM7A.19]

Experimental results for Anti-SEMA7A [IPI-mSEM7A.19] (Addgene #255664) in a flow cytometry assay with ExpiCHO cells expressing human or mouse SEMA7A.
openaire   +2 more sources

Extracellular vesicles of Bacteroides fragilis regulated macrophage polarization through promoted Sema7a expression

Microbial Pathogenesis
Abnormal activation of macrophage and gut Bacteroides fragilis (BF) are the important induction factors in the occurrence of type 2 diabetes (T2D) and vascular complications. However, it remains unknown whether BF involves in macrophage polarization. In this study, we found that BF extracellular vesicles (EV) can be uptaken by macrophage. BF-EV promote
Cong Chen   +4 more
openaire   +2 more sources

Abstract 173: Upregulation of Sema7A Induced by Disturbed Flow Contributes to the Development of Atherosclerosis

Arteriosclerosis, Thrombosis, and Vascular Biology, 2015
Background: Atherosclerosis preferentially develops in areas of arteries with arches and branches, where the flow is disturbed (D-flow). D-flow upregulates proatherogenic genes and promotes the dysfunctional endothelial cell phenotype.
Fei Yang   +3 more
openaire   +1 more source

LncRNA LOXL1‐AS1/miR‐28‐5p/SEMA7A axis facilitates pancreatic cancer progression

Cell Biochemistry and Function, 2019
Pancreatic cancer (PC), one of the most aggressive and lethal human malignancies, is associated with a deplorable prognosis despite progressive therapeutic strategies. Emerging evidence manifests that miR‐28‐5p is involved in several cancers, and its descending expression is associated with poor prognosis.
Yongcun Liu   +3 more
openaire   +2 more sources

ICC/IF for Anti-SEMA7A [IPI-mSEM7A.19] in binding assay

Experimental results for Anti-SEMA7A [IPI-mSEM7A.19] (Addgene #255664) in an immunofluorescence (IF) binding assay with ExpiCHO cells expressing human or mouse SEMA7A.
openaire   +2 more sources

SEMA7A orchestrates the colorectal cancer tumor microenvironment via PlexinC1: coordinating angiogenesis and macrophage M2 polarization

Biochemical Pharmacology
Colorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide, creating an urgent need to identify new therapeutic targets. Semaphorin 7A (SEMA7A), a glycosylphosphatidylinositol (GPI)-anchored protein, has been implicated in tumor progression, but its role in CRC, tumor microenvironment (TME), and inflammation-related CRC remains ...
Ling-Li, Zhang   +3 more
exaly   +3 more sources

ICC/IF for Anti-SEMA7A [IPI-mSEM7A.19] in specificity assay

Experimental results for Anti-SEMA7A [IPI-mSEM7A.19] (Addgene #255664) in an immunofluorescence (IF) specificity assay with ExpiCHO cells expressing human or mouse SEMA7s.
openaire   +1 more source

Anti-SEMA7A [IPI-mSEM7A.19] in immunohistochemistry (IHC) (Mouse)

Experimental results for Anti-SEMA7A [IPI-mSEM7A.19] (Addgene #255664) in an immunohistochemistry (IHC) application on mouse cerebellum.
openaire   +1 more source

A novel heterozygous intron mutation in SEMA7A causing kallmann syndrome in a female

Gynecological Endocrinology, 2020
Lihong Wang, Yongting Zhao, Hui Che
exaly  

Home - About - Disclaimer - Privacy